doi:10.1007/s00394-020-02247-8
A microdosing protocol on a 28-day BUD vial may result in significant waste if the vial contains more doses than you can use in four weeks
GLP-1 medications do not replace physical activity or healthy eating habits as a way to lose weight
00:21:05 Steve Small: Right
The PANTHEON trial, a large double-blind RCT in GOLD defined COPD patients with severe airflow obstruction and a history of 2 COPD exacerbations in the previous year, found that NAC 600 mg BID reduced exacerbation rates in NAC group (497 acute exacerbations in 482 patients, 1.16 AcEx/pt/yr) versus placebo (641 acute exacerbations in 482 patients, 1.49 AcEx/Pt/yr), p 1 log 10 ) compared to untreated controls (67)
No regulatory authority Health Canada, the FDA, the EMA, the TGA, or any equivalent has cleared either component compound, or the blend formulation, as a drug for human or veterinary use